These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8642006)

  • 1. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of 4″-isovaleryl-spiramycin III produced by Bacillus sp. fmbJ.
    Deng Y; Ju Y; Lu Z; Lu F; Yan D; Bie X
    Arch Microbiol; 2014 Feb; 196(2):87-95. PubMed ID: 24356910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H-NMR and 13C-NMR spectral assignments of spiramycins I and III.
    Ramu K; Shringarpure S; Cooperwood S; Beale JM; Williams JS
    Pharm Res; 1994 Mar; 11(3):458-65. PubMed ID: 8008717
    [No Abstract]   [Full Text] [Related]  

  • 4. Mansoquinone: isolation and structure elucidation of new antibacterial aromatic polyketides from terrestrial Streptomyces Sp. Eg5.
    Abdelfattah MS
    Nat Prod Res; 2009; 23(3):212-8. PubMed ID: 19235021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of spiramycin components using high-speed counter-current chromatography.
    Oka H; Harada K; Suzuki M; Ito Y
    J Chromatogr A; 2000 Dec; 903(1-2):93-8. PubMed ID: 11153959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaboratory study comparing the microbiological potency of spiramycins I, II and III.
    Liu L; Saevels J; Louis P; Nelis H; Rico S; Dierick K; Guyomard S; Roets E; Hoogmartens J
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):217-24. PubMed ID: 10704026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of spiramycin and neospiramycin antibiotic residues in raw milk using LC/ESI-MS/MS and solid-phase extraction.
    Wang J; Leung D
    J Sep Sci; 2009 Feb; 32(4):681-8. PubMed ID: 19165836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria.
    Sunazuka T; Shudo H; Nagai K; Yoshida K; Yamaguchi Y; Hanaki H; Omura S
    J Antibiot (Tokyo); 2008 Mar; 61(3):175-84. PubMed ID: 18503196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.
    Wang MJ; Xue J; Zou WB; Wang Y; Hu CQ; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2012 Jul; 66():402-10. PubMed ID: 22482901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation.
    Kimura K; Ikeda Y; Kagami S; Yoshihama M; Ubukata M; Esumi Y; Osada H; Isono K
    J Antibiot (Tokyo); 1998 Jul; 51(7):647-54. PubMed ID: 9727391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
    Sano H; Inoue M; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Demethylmonensins A and B. Novel minor congeners of monensins from Streptomyces cinnamonensis.
    Pospísil S; Sedmera P; Havlícek V
    J Antibiot (Tokyo); 1996 Sep; 49(9):935-7. PubMed ID: 8931729
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary metabolites by chemical screening, 15. Structure and absolute configuration of naphthomevalin, a new dihydro-naphthoquinone antibiotic from Streptomyces sp.
    Henkel T; Zeeck A
    J Antibiot (Tokyo); 1991 Jun; 44(6):665-9. PubMed ID: 1906453
    [No Abstract]   [Full Text] [Related]  

  • 14. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44.
    Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M
    J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049
    [No Abstract]   [Full Text] [Related]  

  • 15. Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.
    Fredenhagen A; Fendrich G; Märki F; Märki W; Gruner J; Raschdorf F; Peter HH
    J Antibiot (Tokyo); 1990 Nov; 43(11):1403-12. PubMed ID: 2125590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two piperazic acid-containing cyclic hexapeptides from Streptomyces alboflavus 313.
    Wei S; Fan L; Wu W; Ji Z
    Amino Acids; 2012 Nov; 43(5):2191-8. PubMed ID: 22543750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldgamycin I, an antibacterial 16-membered macrolide from the abandoned mine bacterium, Streptomyces sp. KMA-001.
    Park JS; Yang HO; Kwon HC
    J Antibiot (Tokyo); 2009 Mar; 62(3):171-5. PubMed ID: 19218982
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydroniphimycin: new polyol macrolide antibiotic produced by Streptomyces hygroscopicus 15 isolation and structure elucidation.
    Ivanova V; Gesheva V; Kolarova M
    J Antibiot (Tokyo); 2000 Jun; 53(6):627-32. PubMed ID: 10966080
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.